Myriad Genetics Inc
NASDAQ:MYGN

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
NASDAQ:MYGN
Watchlist
Price: 6.88 USD -1.57% Market Closed
Market Cap: 641.3m USD

Wall Street
Price Targets

MYGN Price Targets Summary
Myriad Genetics Inc

Wall Street analysts forecast MYGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MYGN is 8.22 USD with a low forecast of 3.54 USD and a high forecast of 18.9 USD.

Lowest
Price Target
3.54 USD
49% Downside
Average
Price Target
8.22 USD
20% Upside
Highest
Price Target
18.9 USD
175% Upside
Myriad Genetics Inc Competitors:
Price Targets
PTCT
PTC Therapeutics Inc
11% Upside
GILD
Gilead Sciences Inc
12% Upside
ORY
Oryzon Genomics SA
149% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
33% Upside
ADMA
ADMA Biologics Inc
45% Upside
ANAB
AnaptysBio Inc
36% Upside
086900
Medy Tox Inc
11% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
11% Upside

Revenue
Forecast

Revenue Estimate
Myriad Genetics Inc

For the last 3 years the compound annual growth rate for Myriad Genetics Inc's revenue is 7%. The projected CAGR for the next 4 years is 4%.

7%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Myriad Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Myriad Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MYGN's stock price target?
Price Target
8.22 USD

According to Wall Street analysts, the average 1-year price target for MYGN is 8.22 USD with a low forecast of 3.54 USD and a high forecast of 18.9 USD.

What is Myriad Genetics Inc's Revenue forecast?
Projected CAGR
4%

For the last 3 years the compound annual growth rate for Myriad Genetics Inc's revenue is 7%. The projected CAGR for the next 4 years is 4%.

Back to Top